Novator's takeover offer furthers Actavis’ growth Skip to content

Novator’s takeover offer furthers Actavis’ growth

Since investment company Novator, owned by Icelandic entrepreneur Björgólfur Thor Björgólfsson, made a bid to take over Icelandic pharmaceutical company Actavis last week, its market value has hit the roof.

According to Fréttabladid supplement Markadurinn, Actavis Group is currently worth more than ISK 290 billion (USD 4.6 billion, EUR 3.4 billion), which means the company’s market value has increased 75 times since its birth in 1999.

The company’s origins can be traced back to when Pharmaco, currently known as Actavis Group, bought Balkanpharma in 1999. Pharmaco’s market worth was ISK 3.8 billion (USD 60 million, EUR 44 million) at the time.

Since 1999, Pharmaco/Actavis has invested in other companies for about ISK 164 billion (USD 2.6 billion, EUR 1.9 billion).

Stockholders in Actavis have seen their shares rise by 50 percent every year since 1999.

Click here to read more about Novator’s takeover offer for Actavis.

Sign up for our weekly newsletter

Get news from Iceland, photos, and in-depth stories delivered to your inbox every week!

* indicates required

Subscribe to Iceland Review

In-depth stories and high-quality photography showcasing life in Iceland!

Share article